Randomised controlled trial of a secondary prevention program for myocardial infarction patients ProActive Heart: study protocolReportar como inadecuado




Randomised controlled trial of a secondary prevention program for myocardial infarction patients ProActive Heart: study protocol - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.

BMC Cardiovascular Disorders

, 9:16

First Online: 09 May 2009Received: 09 March 2009Accepted: 09 May 2009DOI: 10.1186-1471-2261-9-16

Cite this article as: Hawkes, A.L., Atherton, J., Taylor, C.B. et al. BMC Cardiovasc Disord 2009 9: 16. doi:10.1186-1471-2261-9-16

Abstract

BackgroundCoronary heart disease CHD is a significant cause of health and economic burden. Secondary prevention programs play a pivotal role in the treatment and management of those affected by CHD although participation rates are poor due to patient, provider, health system and societal-level barriers. As such, there is a need to develop innovative secondary prevention programs to address the treatment gap. Telephone-delivered care is convenient, flexible and has been shown to improve behavioural and clinical outcomes following myocardial infarction MI. This paper presents the design of a randomised controlled trial to evaluate the efficacy of a six-month telephone-delivered secondary prevention program for MI patients ProActive Heart.

Methods550 adult MI patients have been recruited over a 14 month period December 2007 to January 2009 through two Brisbane metropolitan hospitals, and randomised to an intervention or control group n = 225 per group. The intervention commences within two weeks of hospital discharge delivered by study-trained health professionals -health coaches- during up to 10 × 30 minute scripted telephone health coaching sessions. Participants also receive a ProActive Heart handbook and an educational resource to use during the health coaching sessions. The intervention focuses on appropriate modification of CHD risk factors, compliance with pharmacological management, and management of psychosocial issues. Data collection occurs at baseline or prior to commencement of the intervention Time 1, six months follow-up or the completion of the intervention Time 2, and at 12 months follow-up for longer term outcomes Time 3. Primary outcome measures include quality of life Short Form-36 and physical activity Active Australia Survey. A cost-effective analysis of the costs and outcomes for patients in the intervention and control groups is being conducted from the perspective of health care costs to the government.

DiscussionThe results of this study will provide valuable new information about an innovative telephone-delivered cost-effective secondary prevention program for MI patients.

Trial Registration NumberACTRN12607000595415

Download fulltext PDF



Autor: Anna L Hawkes - John Atherton - C Barr Taylor - Paul Scuffham - Kathy Eadie - Nancy Houston Miller - Brian Oldenburg

Fuente: https://link.springer.com/







Documentos relacionados